Pfizer R&D Sandwich, Kent

Pfizer to retain 350 jobs at Sandwich

June 24, 2011
Research and Development Pfizer, Sandwich, pharma jobs, recruitment

Pfizer has made the surprise decision to retain 350 jobs at its research and development site in Sandwich, Kent, providing …

Roche

Roche and Evotec to collaborate on cancer biomarkers

June 24, 2011
Research and Development Evotec, Roche, biomarkers

Roche and Evotec are to collaborate to find biomarkers for Roche oncology drugs under development. Roche has been one of …

Roche

Roche launches R&D Institute in France

June 24, 2011
Research and Development Roche, translational research

Roche has launched a new R&D Institute in France, furthering its links with academic centres in the country. The Institute, …

succinct_mark_walker

Succinct Communications boosts team

June 24, 2011
Medical Communications appointment, medical communications

Succinct Healthcare Communications has strengthened its team with four new appointments.Andrea Scales joins Amersham, UK-based agency as editorial assistant, James …

Service Insight: Creative consumer communications and pharma

June 24, 2011
Medical Communications Service Insight, advertising, creativity, fmcg

SERVICE INSIGHTI arrived in healthcare communications having spent 12 years as a creative PR consultant within the FMCG and technology …

Menarini pilots UK gout awareness campaign

June 23, 2011
Medical Communications Menarini, disease awareness, disease awareness campaigns

A. Menarini Pharma UK has piloted a new gout awareness campaign in the North East and is preparing to give …

John Burt takes on leadership of PolyTherics

June 23, 2011
Research and Development appointment, research and development

PolyTherics has promoted John Burt from chief business officer to chief executive.Prior to joining PolyTherics, which applies precision chemistry to …

Merck KGaA

Merck scraps MS pill cladribine

June 23, 2011
Research and Development, Sales and Marketing Cladribine, Merck KGaA, Movectro, multiple sclerosis

Merck KGaA has pulled all pending applications for its multiple sclerosis pill Movectro and will withdraw it from the markets …

Sanofi to boost early-stage research with ‘real world’ evidence

June 23, 2011
Research and Development Sanofi, patient data, pharma research

Sanofi is aiming to maximise its R&D investment by including ‘real world’ evidence in its product development strategy. The company …

AstraZeneca sells off dental business for $1.8bn

June 23, 2011
Sales and Marketing AstraZeneca, strategy

AstraZeneca is to sell its dental products firm Astra Tech to DENTSPLY for $1.8 billion. Astra Tech comprises two business …

FDA looks to make drugs risks clearer for patients

June 22, 2011
Medical Communications FDA, advertising

Potential side effects from medicines need to be presented more clearly on prescription drug advertising so patients can understand the …

European approval for BMS kidney transplant drug Nulojix

June 22, 2011
Sales and Marketing BMS, EMA, Nulojix, transplant

European regulators have followed their US counterparts in granting marketing authorisation for a drug which aims to prevent kidney transplant …

Novartis

FDA rejects Novartis’ Ilaris for gouty arthritis

June 22, 2011
Research and Development Ilaris, Novartis, gouty arthritis

An FDA advisory panel has voted against backing Novartis’ Ilaris for gouty arthritis because of safety concerns. Ilaris (canakinumab) is …

Careers in next generation contract partnering

June 22, 2011
Business Services, Manufacturing and Production, Research and Development contract manufacturing, contract research, cros

Over the past few years, a significant shift has occurred in the depth and type of relations that the pharma …

Neurotune chief executive Bruno Oesch

Working Life: Neurotune’s chief executive

June 22, 2011
Business Services, Research and Development Working Life, recruitment

Bruno Oesch, chief executive of Swiss biopharmaceutical company Neurotune, talks to Pharmafocus about being at the interface of science and …

biosector_2_david_kane

David Kane to lead CCC’s Biosector 2

June 22, 2011
Medical Communications appointment, medical communications

Chandler Chicco Companies (CCC) has appointed David Kane as managing director of its healthcare PR agency Biosector 2. He moves …

Health research charities hit back at animal rights campaign

June 21, 2011
Medical Communications Animal testing, Animal tests, Cancer Research UK, animal activists

Four of the UK’s leading health research charities have hit back after being accused of funding “horrific animal experiments” by …

Pfizer

FDA approves Pfizer pain drug Oxecta

June 21, 2011
Sales and Marketing FDA, Oxecta, Pfizer, chronic pain

The FDA has approved Pfizer and Acura’s novel pain drug Oxecta, but will require follow up studies to prove its …

NICE gains expanded role alongside value-based pricing

June 21, 2011
Sales and Marketing NHS reforms, NICE, value-based pricing

NICE will be given a wider remit to oversee social care and its guidance used alongside value-based pricing as part …

The Gateway to Local Adoption Series

Latest content